Skip to main content

Table 2 Multivariate analysis of risk factors associated with biochemical recurrence from prostate cancer after radical prostatectomy in patients with node-positive disease

From: Outcomes of patients with lymph node metastasis treated with radical prostatectomy and adjuvant androgen deprivation therapy in a Chinese population: results from a cohort study

Risk factor

HR (95% CI)

P value (chi-square test)

Preoperative PSA (>=20 ng/ml or not)

0.6(0.3 to 1.4)

0.246

Pathologic Gleason grade (>7 vs. ≤=7)

1.1(0.6 to 2.1)

0.795

Tumor stage (pT3/4 vs. pT2)

1.4(0.6 to 3.0)

0.435

Positive surgical margin

0.9(0.5 to 1.9)

0.853

Positive nodes removed (2 or more vs. 1)

2.6(1.3 to 5.1)

0.005

  1. HR = hazard ratio; CI = confidence interval; PSA =prostate-specific antigen.